Walleye Trading
TEVA icon

Walleye Trading’s Teva Pharmaceuticals TEVA Stock Holding History

Walleye Trading’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15M Sell
499,536
-33,426
-6% -$1.08M 0.03% 617
2025
Q4 		$16.6M Sell
532,962
-557,431
-51% -$13.7M 0.02% 696
2025
Q3 		$22M Buy
1,090,393
+94,129
+9% +$1.65M 0.03% 554
2025
Q2 		$16.7M Buy
996,264
+141,345
+17% +$2.28M 0.03% 602
2025
Q1 		$13.1M Buy
+854,919
New +$15.3M 0.03% 592
2024
Q4 		– Sell
-377,102
Closed -$6.86M – 4667
2024
Q3 		$6.8M Sell
377,102
-267,033
-41% -$4.67M 0.01% 954
2024
Q2 		$10.5M Buy
644,135
+296,909
+86% +$4.57M 0.02% 655
2024
Q1 		$4.9M Sell
347,226
-149,638
-30% -$1.89M 0.01% 1136
2023
Q4 		$5.19M Sell
496,864
-74,430
-13% -$695K 0.01% 1210
2023
Q3 		$5.83M Buy
+571,294
New +$5.32M 0.02% 1012
2020
Q3 		– Sell
-211,175
Closed -$2.23M – 4610
2020
Q2 		$2.6M Buy
211,175
+140,432
+199% +$1.59M 0.02% 909
2020
Q1 		$635K Sell
70,743
-302,725
-81% -$3.1M ﹤0.01% 1669
2019
Q4 		$3.66M Buy
373,468
+225,769
+153% +$2.02M 0.03% 777
2019
Q3 		$1.02M Sell
147,699
-98,027
-40% -$751K 0.01% 1587
2019
Q2 		$2.27M Sell
245,726
-272,612
-53% -$3.29M 0.02% 958
2019
Q1 		$8.13M Buy
518,338
+506,945
+4,450% +$8.94M 0.06% 308
2018
Q4 		$176K Buy
+11,393
New +$234K ﹤0.01% 3501
2017
Q4 		– Sell
-196,691
Closed -$2.96M – 4626
2017
Q3 		$3.46K Buy
196,691
+87,967
+81% +$1.98M 0.02% 897
2017
Q2 		$3.61K Buy
108,724
+10,421
+11% +$323K 0.02% 787
2017
Q1 		$3.15K Buy
98,303
+1,177
+1% +$40.2K 0.02% 750
2016
Q4 		$3.52M Sell
97,126
-241,838
-71% -$9.66M 0.02% 598
2016
Q3 		$15.6M Buy
+338,964
New +$17.7M 0.1% 88
2016
Q2 		– Sell
-24,430
Closed -$1.3M – 5721
2016
Q1 		$1.31M Buy
24,430
+24,025
+5,932% +$1.41M 0.01% 1165
2015
Q4 		$27K Sell
405
-326,829
-100% -$20.2M ﹤0.01% 4259
2015
Q3 		$18.5M Buy
327,234
+9,819
+3% +$637K 0.17% 82
2015
Q2 		$18.8M Buy
317,415
+273,958
+630% +$16.9M 0.19% 72
2015
Q1 		$2.71M Sell
43,457
-8,475
-16% -$493K 0.03% 504
2014
Q4 		$2.99M Buy
+51,932
New +$2.89M 0.03% 501
2014
Q2 		– Sell
-6,118
Closed -$313K – 4021
2014
Q1 		$323 Sell
6,118
-1,943
-24% -$89.8K ﹤0.01% 1589
2013
Q4 		$323K Sell
8,061
-3,345
-29% -$132K ﹤0.01% 1859
2013
Q3 		$431K Sell
11,406
-6,604
-37% -$258K ﹤0.01% 1302
2013
Q2 		$706K Buy
+18,010
New +$701K 0.01% 1064

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Walleye Trading's TEVA Position: Q1 2026 in Review

Walleye Trading reduced its Teva Pharmaceuticals (TEVA) stake by 6.3% in Q1 2026, selling an estimated $1.08M and leaving 499,536 shares worth $15M. The position accounts for 0.03% of the portfolio, ranked #617.

Walleye Trading first reported a position in TEVA in Q2 2013 and has held it in 32 quarters since. The position peaked at $22M in Q3 2025. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Walleye Trading held 499,536 shares of Teva Pharmaceuticals worth $15M as of Q1 2026.
  • Walleye Trading sold 33,426 Teva Pharmaceuticals shares in Q1 2026, an estimated $1.08M.
  • Teva Pharmaceuticals made up 0.03% of Walleye Trading's portfolio in Q1 2026, its #617 holding.
  • Walleye Trading first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 32 quarters since.
  • Walleye Trading's Teva Pharmaceuticals position peaked at $22M in Q3 2025.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.